Royal Bank of Canada’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-500
| Closed | – | – | 6553 |
|
|
2019
Q4 | $0 | Buy |
+500
| New | – | ﹤0.01% | 6504 |
|
|
2019
Q1 | – | Sell |
-2,000
| Closed | -$1K | – | 6081 |
|
|
2018
Q4 | $1K | Sell |
2,000
-89
| -4% | -$45 | ﹤0.01% | 5733 |
|
|
2018
Q3 | $2K | Buy |
2,089
+89
| +4% | +$85 | ﹤0.01% | 5948 |
|
|
2018
Q2 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 5724 |
|
|
2018
Q1 | $4K | Sell |
2,000
-25
| -1% | -$50 | ﹤0.01% | 5404 |
|
|
2017
Q4 | $2K | Hold |
2,025
| – | – | ﹤0.01% | 5569 |
|
|
2017
Q3 | $3K | Buy |
2,025
+25
| +1% | +$37 | ﹤0.01% | 5769 |
|
|
2017
Q2 | $3K | Sell |
2,000
-1,165
| -37% | -$1.75K | ﹤0.01% | 5462 |
|
|
2017
Q1 | $6K | Sell |
3,165
-545
| -15% | -$1.03K | ﹤0.01% | 5484 |
|
|
2016
Q4 | $19K | Buy |
3,710
+1,710
| +86% | +$8.76K | ﹤0.01% | 5051 |
|
|
2016
Q3 | $11K | Hold |
2,000
| – | – | ﹤0.01% | 5000 |
|
|
2016
Q2 | $11K | Hold |
2,000
| – | – | ﹤0.01% | 5020 |
|
|
2016
Q1 | $9K | Sell |
2,000
-41
| -2% | -$185 | ﹤0.01% | 5071 |
|
|
2015
Q4 | $12K | Sell |
2,041
-773
| -27% | -$4.55K | ﹤0.01% | 5156 |
|
|
2015
Q3 | $22K | Buy |
2,814
+1,746
| +163% | +$13.7K | ﹤0.01% | 4946 |
|
|
2015
Q2 | $7K | Buy |
+1,068
| New | +$7K | ﹤0.01% | 5687 |
|